Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT04751487 · COMPLETED
Trial details
- NCT number
- NCT04751487
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-12
- Primary completion
- 2025-04-21
- Enrollment
- 1239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.